For the quarter ending 2025-10-24, MDT made $8,961M in revenue. $1,374M in net income. Net profit margin of 15.33%.
| Income Statement | 2025-10-24 | 2025-07-25 | 2025-04-25 | 2025-01-24 |
|---|---|---|---|---|
| Net sales | 8,961 | 8,578 | 8,927 | 8,292 |
| Cost of products sold, excluding amortization of intangible assets | 3,061 | 3,001 | 3,146 | 2,779 |
| Research and development expense | 754 | 726 | 684 | 675 |
| Selling, general, and administrative expense | 2,965 | 2,806 | 2,720 | 2,717 |
| Amortization of intangible assets | 463 | 459 | 564 | 416 |
| Restructuring charges, net | 10 | 45 | 147 | 43 |
| Certain litigation charges, net | 0 | 27 | 79 | 22 |
| Other operating expense (income), net | -22 | -70 | -15 | 5 |
| Operating profit | 1,686 | 1,445 | 1,436 | 1,646 |
| Other non-operating income, net | 92 | 33 | 0 | 72 |
| Interest expense, net | 181 | 176 | 174 | 179 |
| Income before income taxes | 1,597 | 1,302 | 1,261 | 1,540 |
| Income tax provision | 215 | 255 | 198 | 237 |
| Net income | 1,381 | 1,047 | 1,061 | 1,303 |
| Net income attributable to noncontrolling interests | 7 | 7 | 5 | 9 |
| Net income attributable to medtronic | 1,374 | 1,040 | 1,056 | 1,294 |
| Basic earnings per share (in dollars per share) | 1.07 | 0.81 | 0.82 | 1.01 |
| Basic weighted average shares outstanding (in shares) | 1,282,000,000 | 1,281,600,000 | -2,572,500,000 | 1,282,400,000 |
| Diluted earnings per share (in dollars per share) | 1.07 | 0.81 | 0.81 | 1.01 |
| Diluted weighted average shares outstanding (in shares) | 1,288,000,000 | 1,287,100,000 | -2,579,700,000 | 1,286,200,000 |
Medtronic plc (MDT)
Medtronic plc (MDT)